You have 9 free searches left this month | for more free features.

City

Chilly-Mazarin (1)

Roma (1)

Condition

Thrombotic Thrombocytopenic Purpura (2)

Immune-mediated Thrombocytopenic Purpura (1)

Thrombotic Thrombocytopenic Purpura, Acquired (1)

Overall Status

Not yet recruiting (2)

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Sanofi (2)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

University Hospital, Rouen (1)

Collaborator

Intervention

caplacizumab (4)

anti-cd20 antibody (1)

corticosteroids (1)

Study Documents

Intervention Type

drug (4)

biological (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (2)

Observational (2)

caplacizumab

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

TTP Patients: Italian Experience (ROSCAPLI)

Recruiting

Thrombotic Thrombocytopenic Purpura

Caplacizumab

Roma, Italy

FPG

Mar 14, 2023

Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic

Active, not recruiting

Immune-mediated Thrombocytopenic Purpura

Caplacizumab

Chilly-Mazarin, France

Sanofi-Aventis

Aug 8, 2022

Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

Not yet recruiting

Thrombotic Thrombocytopenic Purpura

Caplacizumab
+2 more

(no location specified)

Aug 8, 2022

Thrombotic Thrombocytopenic Purpura, Acquired Trial (Caplacizumab)

Not yet recruiting

Thrombotic Thrombocytopenic Purpura, Acquired

Caplacizumab

(no location specified)

Jan 19, 2021